Recent investigations indicated that 68Ga-labelled FAP inhibitor (FAPI) shows an equal or even improved tumour imaging with lower background uptake in the liver and the brain in comparison to 18F-FDG in various cancers (17, 18). The gene discussed is FAP; the disease is neoplasm.